Micropaque

Barium sulfate, the active ingredient in Micropaque, is a contrast agent presented as a suspension for oral and rectal use. It creates radiopaque images that enhance visualization of the upper and lower gastrointestinal tract during diagnostic examinations, aiding clinicians in assessing structural abnormalities.

GNH USA supplies Micropaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The company provides reliable logistics, documentation support, and responsive customer service to meet the needs of healthcare providers.

Micropaque is a radiopaque contrast medium used in gastrointestinal imaging procedures.

Upper gastrointestinal tract imaging (barium swallow or meal): Enhances visualization of the esophagus, stomach and duodenum for detection of structural lesions. Lower gastrointestinal tract imaging (barium enema): Provides detailed contrast of the colon and rectum to identify polyps, strictures or inflammatory changes. Combined GI studies: Allows sequential assessment of both upper and lower tracts in comprehensive diagnostic protocols.

Micropaque is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate feeling of queasiness after ingestion. - Vomiting: occasional expulsion of the suspension. - Abdominal cramping: transient discomfort during bowel transit. - Constipation: temporary reduction in bowel movements. - Diarrhea: loose stools in some patients. - Taste alteration: metallic or chalky sensation in the mouth.

Serious or Rare Side Effects: - Aspiration: inhalation of the suspension leading to respiratory irritation. - Severe abdominal pain: may indicate bowel irritation or obstruction. - Bowel perforation: rare but serious injury to the gastrointestinal wall. - Allergic reaction: rash, itching or anaphylaxis in hypersensitive individuals. - Electrolyte imbalance: significant fluid shifts in vulnerable patients. - Severe dehydration: due to prolonged vomiting or diarrhea.

Use of Micropaque requires careful patient assessment and preparation. - Gastrointestinal obstruction: assess for any known blockage before administration. - Hypersensitivity: confirm no prior allergic reaction to barium sulfate. - Recent bowel perforation: avoid use in patients with recent perforation or surgery. - Hydration: ensure adequate fluid intake before and after the procedure to aid clearance. - Dysphagia monitoring: observe for aspiration risk in patients with swallowing difficulties. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Micropaque may interact with other agents that affect gastrointestinal function or imaging quality.

Major Interactions (Avoid): - High‑dose oral iron supplements: can reduce contrast quality. - Concurrent radiopaque agents in the same study: may cause image artifacts. - Antacids containing aluminum or magnesium: may interfere with barium coating.

Moderate Interactions (Monitor Closely): - Laxatives: may alter transit time and affect imaging results. - Anticoagulants: increased risk of gastrointestinal bleeding if mucosal injury occurs. - Constipation‑inducing medications: may exacerbate discomfort or delay barium clearance.